Aspire Biopharma Holdings, Inc.

Aspire Biopharma Holdings, Inc., trading under the ticker PWUP, is a Special Purpose Acquisition Company operating in the biopharmaceutical sector. The company filed an 8-K current report with the Securities and Exchange Commission on August 19, 2026, under accession number 0001493152-26-039135, reflecting a reportable corporate event during its SPAC lifecycle. As a biopharma-focused blank check company, PWUP is targeting merger or acquisition opportunities within the life sciences and drug development space. Investors and analysts tracking the deal can access the full filing history, sponsor disclosures, warrant data, and transaction timelines for PWUP on SpacDesk—sign up today for complete, real-time SPAC intelligence.